Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Delayed Data
As of Jan 18
 +0.97 / +1.19%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 21 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 100.00, with a high estimate of 145.00 and a low estimate of 75.00. The median estimate represents a +21.18% increase from the last price of 82.52.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 67.29%
Growthannually 170.23%


Growthquarterly 8.27%
Growthannually 64.17%
Key to the earnings and sales forecast charts.